Toggle light / dark theme

Bongard said they found that the xenobots, which were initially sphere-shaped and made from around 3,000 cells, could replicate. But it happened rarely and only in specific circumstances. The xenobots used “kinetic replication” — a process that is known to occur at the molecular level but has never been observed before at the scale of whole cells or organisms, Bongard said.


The US scientists who created the first living robots say the life forms, known as xenobots, can now reproduce — and in a way not seen in plants and animals.

Formed from the stem cells of the African clawed frog (Xenopus laevis) from which it takes its name, xenobots are less than a millimeter (0.04 inches) wide. The tiny blobs were first unveiled in 2020 after experiments showed that they could move, work together in groups and self-heal.

Now the scientists that developed them at the University of Vermont, Tufts University and Harvard University’s Wyss Institute for Biologically Inspired Engineering said they have discovered an entirely new form of biological reproduction different from any animal or plant known to science.

With Gauss Rifles [military squads] could pitch a solar panel, charge their guns’ batteries, and fire nuts and bolts off the ground as ammunition.


“You can hold far more energy in batteries than you can with gunpowder,” Wirth told Futurism. And a battery eliminates the need for “explosive chemical propellants.”

But it’s an entirely new type of armament that could have some potentially dangerous consequences, opening the doors to turn anything from metal rods to nuts and bolts into deadly projectiles. And its creators are already imagining military applications.

“Imagine a scenario where a military squad is pinned down behind enemy lines and they’re out of ammunition,” Wirth told us. “With Gauss Rifles they could pitch a solar panel, charge their guns’ batteries, and fire nuts and bolts off the ground as ammunition.”

Blackholes are a breakdown in the equations of spacetime. This means both space and time no longer behave the way we would expect of them.
Today we explore the breakdown in time around blackholes and what it means to interact with the event horizon, or the place where time appears to stand still.

Further Reading/Consumption:

Black holes & time warps: einstein’s outrageous legacy — kip thorne.

Your Daily Equation #31: BLACK HOLES: And Why Time Slows Down When You Are Near One — https://youtu.be/qph51qUgwgU

What happens to you if you fall into a black hole? — https://math.ucr.edu/home/baez/physics/Relativity/BlackHoles/fall_in.html.

Physics Beyond the Event Horizon — https://knotphysics.net/black-holes

Circa 2017


“Enabling early detection of diseases is one of the greatest opportunities we have for developing effective treatments,” Esfandyarpour said. “Maybe $1 in the U.S. doesn’t count that much, but somewhere in the developing world, it’s a lot of money.”

A two-part system

A combination of microfluidics, electronics and inkjet printing technology, the lab-on-a-chip is a two-part system: A clear silicone microfluidic chamber for housing cells sits on top of a reusable electronic strip.

Circa 2018 #artificialintelligence #doctor


Abstract: Online symptom checkers have significant potential to improve patient care, however their reliability and accuracy remain variable. We hypothesised that an artificial intelligence (AI) powered triage and diagnostic system would compare favourably with human doctors with respect to triage and diagnostic accuracy. We performed a prospective validation study of the accuracy and safety of an AI powered triage and diagnostic system. Identical cases were evaluated by both an AI system and human doctors. Differential diagnoses and triage outcomes were evaluated by an independent judge, who was blinded from knowing the source (AI system or human doctor) of the outcomes. Independently of these cases, vignettes from publicly available resources were also assessed to provide a benchmark to previous studies and the diagnostic component of the MRCGP exam. Overall we found that the Babylon AI powered Triage and Diagnostic System was able to identify the condition modelled by a clinical vignette with accuracy comparable to human doctors (in terms of precision and recall). In addition, we found that the triage advice recommended by the AI System was, on average, safer than that of human doctors, when compared to the ranges of acceptable triage provided by independent expert judges, with only a minimal reduction in appropriateness.

From: Yura Perov N [view email]

[v1] Wed, 27 Jun 2018 21:18:37 UTC (54 KB)

Biodiversity conservation, public health and improved livelihoods — dr gladys kalema-zikusoka, founder and CEO, conservation through public health.


Dr. Gladys Kalema-Zikusoka, is the Founder and CEO of Conservation Through Public Health (CTPH — https://ctph.org/), a 16-year old non-profit organization, based in Uganda, that promotes conservation by improving the quality of life of people and wildlife to enable them to coexist in and around protected areas in Africa, and she has become one of the leading conservationists and scientists working to save the critically endangered mountain gorillas of East Africa.

Dr. Kalema-Zikusoka is also on the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) of the World Health Organization (https://www.who.int/groups/scientific-advisory-group-on-the-…ago)/about)

Dr. Kalema-Zikusoka trained as a veterinarian at the University of London’s Royal Veterinary College. Between 1996 and 2000, she set up the first Veterinary Unit at the Uganda Wildlife Authority. From 2000 to 2003, she completed a zoological medicine residency and masters in specialized veterinary medicine at North Carolina State University and North Carolina Zoological Park.

Dr. Kalema-Zikusoka became an Ashoka Fellow in 2007 for merging Uganda’s wildlife management and rural public health programs to create common resources for both people and animals.

Bridging Technology And Medicine For The Modern Healthcare Ecosystem — Dr. Mona G. Flores, MD, Global Head of Medical AI, NVIDIA.


Dr. Mona Flores M.D., is the Global Head of Medical AI, at NVIDIA (https://blogs.nvidia.com/blog/author/monaflores/), the American multinational technology company, where she oversees the company’s AI initiatives in medicine and healthcare to bridge the chasm between technology and medicine.

Dr. Flores first joined NVIDIA in 2018 with a focus on developing their healthcare ecosystem. Before joining NVIDIA, she served as the chief medical officer of digital health company Human-Resolution Technologies after a 25+ year career in medicine and cardiothoracic surgery.

Dr. Flores received her medical degree from Oregon Health and Science University, followed by a general surgery residency at the University of California at San Diego, a Postdoctoral Fellowship at Stanford, and a cardiothoracic surgery residency and fellowship at Columbia University in New York.

Dr. Flores also has a Masters of Biology from San Jose State and an MBA from the University at Albany School of Business. She initially worked in investment banking for a few years before pursuing her passion for medicine and technology.